IFP Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08K | Buy |
+385
| New | +$3.08K | ﹤0.01% | 3683 |
|
|
2025
Q1 | – | Sell |
-3
| Closed | -$17 | – | 4424 |
|
|
2024
Q4 | $17 | Buy |
+3
| New | +$17 | ﹤0.01% | 4475 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3683 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3421 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3334 |
|
|
2020
Q4 | – | Sell |
-259
| Closed | -$11K | – | 3234 |
|
|
2020
Q3 | $11K | Buy |
+259
| New | +$11K | ﹤0.01% | 1859 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2981 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2975 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3047 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3214 |
|
|
2018
Q4 | – | Sell |
-136
| Closed | -$12K | – | 3568 |
|
|
2018
Q3 | $12K | Hold |
136
| – | – | ﹤0.01% | 2708 |
|
|
2018
Q2 | $16K | Hold |
136
| – | – | ﹤0.01% | 2562 |
|
|
2018
Q1 | $8K | Hold |
136
| – | – | ﹤0.01% | 2912 |
|
|
2017
Q4 | $8K | Hold |
136
| – | – | ﹤0.01% | 2909 |
|
|
2017
Q3 | $6K | Hold |
136
| – | – | ﹤0.01% | 3251 |
|
|
2017
Q2 | $5K | Hold |
136
| – | – | ﹤0.01% | 3349 |
|
|
2017
Q1 | $4K | Sell |
136
-175
| -56% | -$5.15K | ﹤0.01% | 3365 |
|
|
2016
Q4 | $10K | Buy |
311
+136
| +78% | +$4.37K | ﹤0.01% | 2866 |
|
|
2016
Q3 | $5K | Sell |
175
-1,476
| -89% | -$42.2K | ﹤0.01% | 3198 |
|
|
2016
Q2 | $36K | Buy |
+1,651
| New | +$36K | ﹤0.01% | 1957 |
|
|
2016
Q1 | – | Sell |
-1,714
| Closed | -$57K | – | 2656 |
|
|
2015
Q4 | $57K | Buy |
+1,714
| New | +$57K | ﹤0.01% | 1516 |
|